
GPN Vaccines
Developer of vaccines intended to offer protection against pneumococcal bacteria, the world's foremost bacterial pathogen. The company's vaccine is developed by using a gamma-irradiation process that ...
Valuation
$0
Share Price
N/A
Total Raised
$24.2M
Last Round
N/A